Edaravone: a new treatment for ALS on the horizon?

@article{Hardiman2017EdaravoneAN,
  title={Edaravone: a new treatment for ALS on the horizon?},
  author={O. Hardiman and L. Berg},
  journal={The Lancet Neurology},
  year={2017},
  volume={16},
  pages={490-491}
}
  • O. Hardiman, L. Berg
  • Published 2017
  • Medicine
  • The Lancet Neurology
  • 49 Citations

    Topics from this paper.

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    Given the role of adaptive immunity in ALS, the pathogenicity of some clostridial strains on motorneurons, the putative role of cyanobacteria in ALS development, and the increasing… Expand
    ConditionsAmyotrophic Lateral Sclerosis
    InterventionBiological
    Is the number of patients with motor neuron disease increasing?
    • Läkarprogrammet termin
    • 2018
    Amyotrophic lateral sclerosis
    • 18
    • PDF
    Amyotrophic lateral sclerosis
    • 18
    • PDF
    Amyotrophic lateral sclerosis: A guide to collaborative care
    • Carrie Smith Nold
    • Medicine
    • JAAPA : official journal of the American Academy of Physician Assistants
    • 2018
    • 1
    Cost vs care

    References

    SHOWING 1-8 OF 8 REFERENCES
    Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study)
    • Hiide Yoshino, A. Kimura
    • Medicine
    • Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
    • 2006
    • 147
    The changing picture of amyotrophic lateral sclerosis: lessons from European registers
    • 58
    • PDF